XPeng Inc has a consensus price target of $21.8 based on the ratings of 17 analysts. The high is $36.3 issued by Nomura Instinet on July 1, 2022. The low is $8 issued by Daiwa Capital on December 14, 2022. The 3 most-recent analyst ratings were released by Macquarie, Barclays, and JP Morgan on May 22, 2025, March 20, 2025, and March 19, 2025, respectively. With an average price target of $25 between Macquarie, Barclays, and JP Morgan, there's an implied 24.44% upside for XPeng Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/22/2025 | Buy Now | 19.46% | Macquarie | Eugene Hsiao25% | → $24 | Upgrade | Neutral → Outperform | Get Alert |
03/20/2025 | Buy Now | -0.45% | Barclays | Jiong Shao69% | $7 → $20 | Maintains | Underweight | Get Alert |
03/19/2025 | Buy Now | 54.31% | JP Morgan | Nick Lai31% | $35 → $31 | Maintains | Overweight | Get Alert |
03/19/2025 | Buy Now | 34.4% | B of A Securities | Ming Hsun Lee44% | $18.6 → $27 | Maintains | Buy | Get Alert |
03/10/2025 | Buy Now | 44.35% | Citigroup | Jeff Chung32% | $13.7 → $29 | Upgrade | Neutral → Buy | Get Alert |
02/24/2025 | Buy Now | -10.4% | UBS | Paul Gong27% | $8.8 → $18 | Upgrade | Sell → Neutral | Get Alert |
02/07/2025 | Buy Now | -10.4% | Macquarie | Eugene Hsiao25% | → $18 | Downgrade | Outperform → Neutral | Get Alert |
12/05/2024 | Buy Now | -56.2% | UBS | Paul Gong27% | $8.2 → $8.8 | Downgrade | Neutral → Sell | Get Alert |
11/22/2024 | Buy Now | -16.87% | China Renaissance | Yiming Wang29% | → $16.7 | Upgrade | Hold → Buy | Get Alert |
11/20/2024 | Buy Now | -31.81% | Citigroup | Jeff Chung32% | $14.6 → $13.7 | Maintains | Neutral | Get Alert |
11/20/2024 | Buy Now | -30.31% | Bernstein | Eunice Lee23% | $9 → $14 | Maintains | Market Perform | Get Alert |
09/05/2024 | Buy Now | -42.76% | JP Morgan | Nick Lai31% | $8 → $11.5 | Upgrade | Neutral → Overweight | Get Alert |
08/21/2024 | Buy Now | -62.17% | Citigroup | Jeff Chung32% | $8.3 → $7.6 | Maintains | Neutral | Get Alert |
08/21/2024 | Buy Now | -50.22% | B of A Securities | Ming Hsun Lee44% | $11 → $10 | Maintains | Buy | Get Alert |
08/21/2024 | Buy Now | -60.18% | JP Morgan | Nick Lai31% | $9 → $8 | Maintains | Neutral | Get Alert |
07/16/2024 | Buy Now | -41.76% | B of A Securities | Ming Hsun Lee44% | $12.7 → $11.7 | Maintains | Buy | Get Alert |
06/25/2024 | Buy Now | -58.69% | Citigroup | Jeff Chung32% | $7.7 → $8.3 | Upgrade | Sell → Neutral | Get Alert |
04/15/2024 | Buy Now | -65.16% | Macquarie | Eugene Hsiao25% | → $7 | Reinstates | → Neutral | Get Alert |
03/11/2024 | Buy Now | -10.4% | Morgan Stanley | Tim Hsiao30% | $23.1 → $18 | Maintains | Overweight | Get Alert |
02/23/2024 | Buy Now | -55.2% | JP Morgan | Nick Lai31% | $19 → $9 | Maintains | Neutral | Get Alert |
09/22/2023 | Buy Now | 26.43% | Morgan Stanley | Tim Hsiao30% | $25.4 → $25.4 | Reiterates | Overweight → Overweight | Get Alert |
08/22/2023 | Buy Now | -60.18% | Barclays | Jiong Shao69% | $6 → $8 | Maintains | Underweight | Get Alert |
08/21/2023 | Buy Now | -20.36% | JP Morgan | Nick Lai31% | $18 → $16 | Maintains | Neutral | Get Alert |
08/21/2023 | Buy Now | 9.51% | B of A Securities | Ming Hsun Lee44% | $16.3 → $22 | Upgrade | Neutral → Buy | Get Alert |
08/08/2023 | Buy Now | 19.46% | CLSA | Ding Luo8% | → $24 | Upgrade | Outperform → Buy | Get Alert |
08/07/2023 | Buy Now | 9.51% | HSBC | Yuqian Ding28% | → $22 | Upgrade | Hold → Buy | Get Alert |
08/02/2023 | Buy Now | -25.34% | Citigroup | Jeff Chung32% | $6.28 → $15 | Maintains | Sell | Get Alert |
07/31/2023 | Buy Now | 14.48% | UBS | Paul Gong27% | → $23 | Downgrade | Buy → Neutral | Get Alert |
07/28/2023 | Buy Now | 25.93% | Jefferies | Johnson Wan20% | $7.8 → $25.3 | Upgrade | Hold → Buy | Get Alert |
07/21/2023 | Buy Now | -50.22% | JP Morgan | Nick Lai31% | $7.5 → $10 | Downgrade | Neutral → Underweight | Get Alert |
07/11/2023 | Buy Now | — | Goldman Sachs | Tina Hou57% | — | Initiates | → Buy | Get Alert |
07/07/2023 | Buy Now | -47.74% | BOCOM International | Angus Chan69% | → $10.5 | Downgrade | Neutral → Sell | Get Alert |
06/30/2023 | Buy Now | -34.79% | CLSA | Ding Luo8% | $10 → $13.1 | Upgrade | Buy → Outperform | Get Alert |
06/16/2023 | Buy Now | -41.76% | B of A Securities | Ming Hsun Lee44% | $9.8 → $11.7 | Maintains | Neutral | Get Alert |
05/25/2023 | Buy Now | -51.22% | B of A Securities | Ming Hsun Lee44% | $11 → $9.8 | Maintains | Neutral | Get Alert |
05/25/2023 | Buy Now | -70.13% | Barclays | Jiong Shao69% | $8 → $6 | Downgrade | Equal-Weight → Underweight | Get Alert |
04/25/2023 | Buy Now | -53.71% | Jefferies | Johnson Wan20% | $4.2 → $9.3 | Upgrade | Underperform → Hold | Get Alert |
03/24/2023 | Buy Now | -40.27% | Bernstein | Eunice Lee23% | $16 → $12 | Downgrade | Outperform → Market Perform | Get Alert |
03/18/2023 | Buy Now | -46.74% | B of A Securities | Ming Hsun Lee44% | $11 → $10.7 | Maintains | Neutral | Get Alert |
01/11/2023 | Buy Now | -55.2% | JP Morgan | Nick Lai31% | $11 → $9 | Downgrade | Overweight → Neutral | Get Alert |
01/06/2023 | Buy Now | — | B of A Securities | Ming Hsun Lee44% | — | Downgrade | Buy → Neutral | Get Alert |
12/14/2022 | Buy Now | -60.18% | Daiwa Capital | Kelvin Lau24% | $13 → $8 | Downgrade | Buy → Sell | Get Alert |
12/13/2022 | Buy Now | -25.34% | HSBC | Yuqian Ding28% | $34 → $15 | Maintains | Buy | Get Alert |
12/02/2022 | Buy Now | -43.75% | China Renaissance | Yiming Wang29% | $40.5 → $11.3 | Downgrade | Buy → Hold | Get Alert |
11/28/2022 | Buy Now | -79.09% | Jefferies | Johnson Wan20% | $18.6 → $4.2 | Downgrade | Hold → Underperform | Get Alert |
11/17/2022 | Buy Now | -35.29% | UBS | Paul Gong27% | $34 → $13 | Upgrade | Neutral → Buy | Get Alert |
10/28/2022 | Buy Now | -84.17% | Citigroup | Jeff Chung32% | → $3.18 | Downgrade | Buy → Sell | Get Alert |
10/28/2022 | Buy Now | -60.18% | Barclays | Jiong Shao69% | $22 → $8 | Maintains | Equal-Weight | Get Alert |
08/24/2022 | Buy Now | 38.73% | Citigroup | Jeff Chung32% | $51.59 → $27.87 | Maintains | Buy | Get Alert |
08/24/2022 | Buy Now | 9.51% | Barclays | Jiong Shao69% | $30 → $22 | Downgrade | Overweight → Equal-Weight | Get Alert |
08/03/2022 | Buy Now | 24.44% | Macquarie | Erica Chen6% | → $25 | Downgrade | Outperform → Neutral | Get Alert |
07/01/2022 | Buy Now | 80.69% | Nomura Instinet | Martin Heung9% | → $36.3 | Downgrade | Buy → Neutral | Get Alert |
06/21/2022 | Buy Now | 156.79% | Citigroup | Jeff Chung32% | $36.7 → $51.59 | Maintains | Buy | Get Alert |
05/24/2022 | Buy Now | 74.22% | JP Morgan | Nick Lai31% | $42 → $35 | Maintains | Overweight | Get Alert |
05/24/2022 | Buy Now | 49.33% | Barclays | Jiong Shao69% | $39 → $30 | Maintains | Overweight | Get Alert |
05/24/2022 | Buy Now | 99.1% | B of A Securities | Ming Hsun Lee44% | $46 → $40 | Maintains | Buy | Get Alert |
The latest price target for XPeng (NYSE:XPEV) was reported by Macquarie on May 22, 2025. The analyst firm set a price target for $24.00 expecting XPEV to rise to within 12 months (a possible 19.46% upside). 17 analyst firms have reported ratings in the last year.
The latest analyst rating for XPeng (NYSE:XPEV) was provided by Macquarie, and XPeng upgraded their outperform rating.
The last upgrade for XPeng Inc happened on May 22, 2025 when Macquarie raised their price target to $24. Macquarie previously had a neutral for XPeng Inc.
The last downgrade for XPeng Inc happened on February 7, 2025 when Macquarie changed their price target from N/A to $18 for XPeng Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of XPeng, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for XPeng was filed on May 22, 2025 so you should expect the next rating to be made available sometime around May 22, 2026.
While ratings are subjective and will change, the latest XPeng (XPEV) rating was a upgraded with a price target of $0.00 to $24.00. The current price XPeng (XPEV) is trading at is $20.09, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.